Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05479812
Title Dose Escalation Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Werewolf Therapeutics, Inc.
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
HonorHealth RECRUITING Scottsdale Arizona 85258 United States Details
Emory Winship Cancer Institute RECRUITING Atlanta Georgia 30322 United States Details
Northwestern University RECRUITING Chicago Illinois 60611 United States Details
Indiana University Melvin and Bren Simon Comprehensive Cancer Center RECRUITING Indianapolis Indiana 46202 United States Details
Roswell Park Comprehensive Cancer Care RECRUITING Buffalo New York 14203 United States Details
Westchester Medical Center RECRUITING Hawthorne New York 10532 United States Details
Providence Cancer Institute Franz Clinic RECRUITING Portland Oregon 97213 United States Details
NEXT Oncology RECRUITING San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from for the field